Table 1

Clinical characteristics of patients with MND

All MND patients (n=37) MND patients with 0–2 coughing episodes in 3 days (n=15) (group 1) MND patients with >2 coughing episodes in 3 days (n=22) (group 2) p Value
Sex
Female (%)12 (32)2 (13)10 (45)0.031-150
 Male (%)25 (68)13 (87)12 (55)
Age ((y) mean (SD))66 (11)61 (12)70 (8)0.015§
Duration of symptoms ((y) mean (SD))4.0 (4.3)5.0 (4.6)3.6 (3.6)0.36§
Timed test of swallowing vol/time ((ml/s) % pred mean (SD))49 (45)71 (48)33 (33)0.009§
Bulbar signs
Normal (%)11 (28)6 (40)4 (18)>0.051-150
 LMN (%)11 (28)4 (26)7 (32)
 UMN (%)10 (27)5 (34)6 (27)
 UMN+LMN (%)5 (17)0 (0)5 (23)
Speech
Normal (%)13 (35)9 (58)4 (18)0.021-150
 Abnormal (%)24 (65)6 (42)18 (82)
FVC % (pred mean (SD))60 (20)70 (22)56 (14)0.0391-151
Oral secretions
Normal or dry (%)25 (68)11 (73)14 (64)>0.21-150
 Excess (%)12 (32)4 (27)8 (36)
Smoking
No (%)25 (68)11 (73)13 (59)>0.21-150
 Yes (%)12 (32)4 (27)9 (41)
Anxiety
No (%)30 (81)12 (80)20 (91)>0.21-150
 Yes1-152 (%)7 (19)3 (20)2 (9)
Depression
No (%)31 (84)14 (93)19 (86)>0.21-150
 Yes1-152 (%)6 (16)1 (7)3 (14)
  • 1-150 χ2 test;

  • 1-151 Kruskal Wallis test; p refers to comparison between groups 1 and 2;

  • 1-152 hospital anxiety depression scale ⩾11.